Literature DB >> 14007151

A comparison of tests for antifibrillatory action.

E M WILLIAMS, L SZEKERES.   

Abstract

THE OBJECT OF THE EXPERIMENTS WAS TWOFOLD: first, to choose the most satisfactory test for antifibrillatory action; secondly, to place several drugs with reputed antifibrillatory activity in an order of potency as a preliminary to investigating their mode of action. Measurements were made on isolated rabbit atria at 34 degrees C of (1) the maximum driving frequency the atria would follow, (2) conduction velocity, (3) contractions, and of the threshold for the production of (4) extrasystoles, (5) flutter and (6) fibrillation. Log dose-response curves were plotted for quinidine, papaverine, procaine, dibenamine and procaine amide. The maximum frequency test and fibrillation threshold test gave similar results with all the drugs, and the results gave the order quinidine 1.0, procaine 0.53, Dibenamine 0.47, papaverine 0.43 and procainamide 0.26. Thresholds for extrasystoles and flutter were much more variable. The regressions relating changes in conduction velocity and contraction to log dose were different from those for maximum driving frequency and fibrillation threshold for procaine, papaverine and dibenamine, but the regressions for quinidine and procaine amide were nearly parallel in all tests. Serpajmaline contained a substance with antifibrillatory activity as great as that of quinidine and with no greater depressant action on contractions.

Entities:  

Keywords:  MYOCARDIAL DEPRESSANTS/pharmacology

Mesh:

Substances:

Year:  1961        PMID: 14007151      PMCID: PMC1482103          DOI: 10.1111/j.1476-5381.1961.tb01129.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  7 in total

1.  Single fiber recording of the effects of quinidine at atrial and pacemaker sites in the isolated right atrium of the rabbit.

Authors:  T C WEST; D W AMORY
Journal:  J Pharmacol Exp Ther       Date:  1960-10       Impact factor: 4.030

2.  [Change in the fibrillation threshold of auricular and ventricular musculature of isolated mammalian heart after cooling and after administration of various pharmacological agents].

Authors:  L SZEKERES; G LENARD
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1960

3.  The cause of fibrillation.

Authors:  J H BURN
Journal:  Br Med J       Date:  1960-05-07

4.  The effects of acetylcholine in the heart-lung preparation including the production of auricular fibrillation.

Authors:  J H BURN; E M V WILLIAMS; J M WALKER
Journal:  J Physiol       Date:  1955-05-27       Impact factor: 5.182

5.  The refractory period of atria isolated from mammalian hearts.

Authors:  G S DAWES; J R VANE
Journal:  J Physiol       Date:  1956-06-28       Impact factor: 5.182

6.  Antifibrillatory drugs.

Authors:  J R DIPALMA; J E SCHULTZ
Journal:  Medicine (Baltimore)       Date:  1950-05       Impact factor: 1.889

7.  The mode of action of quinidine on isolated rabbit atria interpreted from intracellular potential records.

Authors:  E M VAUGHAN WILLIAMS
Journal:  Br J Pharmacol Chemother       Date:  1958-09
  7 in total
  18 in total

1.  Investigations to characterize a new anti-arrhythmic drug, ORG 6001 including a simple test for calcium antagonism.

Authors:  L A Salako; V Williams; J H Wittig
Journal:  Br J Pharmacol       Date:  1976-06       Impact factor: 8.739

2.  THE EFFECTS ON CARDIAC MUSCLE OF BETA-RECEPTOR ANTAGONISTS IN RELATION TO THEIR ACTIVITY AS LOCAL ANAESTHETICS.

Authors:  A MORALES AGUILERA; E M VAUGHANWILLIAMS
Journal:  Br J Pharmacol Chemother       Date:  1965-04

3.  Antiarrhythmic drug research.

Authors:  M J A Walker
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

4.  Antifibrillatory action.

Authors:  L Szekeres; E M Williams
Journal:  J Physiol       Date:  1962-03       Impact factor: 5.182

5.  Effects of Droperidol on sheep Purkinje fibers.

Authors:  O Hauswirth
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

6.  Antiarrhythmic action of sparteine on direct and indirect models of cardiac fibrillation.

Authors:  J Senges; L Ehe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

7.  Synergistic interaction between histamine and ouabain on ventricular fibrillation threshold.

Authors:  J P Trzeciakowski
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739

8.  A comparison of the anti-arrhythmic actions of I.C.I. 50172 and (--)-propranolol and their effects on intracellular cardiac action potentials and other features of cardiac function.

Authors:  J G Papp; E M Williams
Journal:  Br J Pharmacol       Date:  1969-10       Impact factor: 8.739

9.  Antimuscarinic action of quinidine on the heart? A study in myocardial preparations from cat hearts.

Authors:  H Nawrath; U Sack; X Zong
Journal:  Br J Pharmacol       Date:  1984-01       Impact factor: 8.739

10.  Effects on cardiac muscle of the -adrenoceptor blocking drugs INPEA and LB46 in relation to their local anaesthetic action on nerve.

Authors:  B N Singh; E M Williams
Journal:  Br J Pharmacol       Date:  1971-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.